FDA Approved: FOSAPREPITANT DIMEGLUMINE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved fosaprepitant dimeglumine from Hikma as a generic injectable antiemetic to prevent chemotherapy- and postoperative-induced nausea and vomiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• fosaprepitant dimeglumine (fosaprepitant dimeglumine)

Snippet

ORIG AP for FOSAPREPITANT DIMEGLUMINE (FOSAPREPITANT DIMEGLUMINE)